Cartesian Therapeutics (RNAC) jumped over 30% on Tuesday after announcing a licensing deal to develop its CAR-T cell therapies using a drug delivery technology developed by the mRNA therapeutics ...
Hosted on MSN
Pursuing the 'golden mean' between pen and sword
It was a great privilege to have even a small portion of my life story and my philosophy featured even once in the Chosun Ilbo. So when I received an invitation to write a regular column I was both ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results